Sherwin-Williams has delivered a 36.4% gain over the past three years, yet its recent share price softness and mixed profit picture put the focus squarely on what investors are paying for its cash flows today. With the stock last closing at US$332.61, the question is how well that market value lines up with the cash the business can generate over time.
The stock's next move may depend on whether the Discounted Cash Flow (DCF) view of Sherwin-Williams' future cash flows supports what investors are currently paying for the shares.
If you are testing whether Sherwin-Williams' recent 36.4% three year gain still stacks up against its cash flows, it can help to compare it with 33 high quality undervalued stocks.
The Discounted Cash Flow (DCF) model here focuses on the cash Sherwin-Williams can return to shareholders over time. Latest twelve month free cash flow sits at about $2.8b, and the projections used in this 2 Stage Free Cash Flow to Equity model assume that cash generation grows from that base rather than shrinking.
Those rising cash flow estimates, when discounted back and compared with the share price of US$332.61, lead to an estimated intrinsic value that the DCF output places meaningfully above where the stock trades today. The recent Q3 2026 update, which combined higher sales with some pressure on profits and free cash flow, helps explain why the market is still pricing Sherwin-Williams below what these cash flow projections suggest. Find out what Sherwin-Williams could be worth using our Discounted Cash Flow (DCF) estimate.
Narratives on Sherwin-Williams pick up where the cash flow puzzle leaves off by spelling out which paths for revenue, margins and earnings would need to play out for the share price to look meaningfully higher or lower than it does today on Simply Wall St's Community page. Each scenario links a fair value to a clear storyline around potential catalysts and practical risks, so you can track over time which version of Sherwin-Williams' future appears to be unfolding.
One of the top community narratives on Sherwin-Williams: roughly fairly valued
"The main factor that has to go right is Sherwin-Williams continuing to offset higher raw material costs with targeted pricing, product mix, and cost control…"
Discover why this Narrative puts Sherwin-Williams at roughly fairly valued.
Valuation only tells part of the Sherwin-Williams story, since recent research checks have also raised specific areas of concern that investors may want to weigh before making any decision. Take a closer look at 2 warning signs before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com